Tamoxifen for early breast cancer: an overview of the randomised trials

Keywords

TamoxifenMedicineBreast cancerOncologyAdjuvantClinical trialRandomized controlled trialInternal medicineGynecologyCancerAntiestrogen

Affiliated Institutions

Related Publications

National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000

Patricia J. Eifel , Jan Axelson , Janitha Costa +11 more

The panel concludes that decisions regarding adjuvant hormonal therapy should be based on the presence of hormone receptor protein in tumor tissues. Adjuvant hormonal therapy sh...

2001 JNCI Journal of the National Cancer I... 894 citations

Polychemotherapy for early breast cancer: an overview of the randomised trials

Mary Clarke , Rory Collins , Claire Davies +3 more

1998 The Lancet 2040 citations

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

Ahmedin Jemal , Elizabeth Ward , Michael J. Thun

Abstract Introduction A recent abstract presented in a breast cancer symposium attributed the sharp decrease in female breast cancer incidence rates from 2002 to 2003 in the Sur...

2007 Breast Cancer Research 352 citations

The Decrease in Breast-Cancer Incidence in 2003 in the United States

Peter M. Ravdin , Kathleen A. Cronin , Nadia Howlader +5 more

An initial analysis of data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registries shows that the age-adjusted incidence rate of brea...

2007 New England Journal of Medicine 974 citations

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer , Christina Lacchetti , Bryan J. Schneider +26 more

Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint i...

2018 Journal of Clinical Oncology 3484 citations

Publication Info

Year: 1998
Type: article
Volume: 351
Issue: 9114
Pages: 1451-1467
Citations: 4091
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Tamoxifen for early breast cancer: an overview of the randomised trials

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

4091

OpenAlex

Cite This

APA Style

                            
                                
                                    Mike Clarke, 
                                
                                    R Collins, 
                                
                                    Claire Davies
                                
                                et al.
                            
                            (1998). 
                            Tamoxifen for early breast cancer: an overview of the randomised trials. 
                            The Lancet
                            , 351
                            (9114)
                            , 1451-1467.
                            https://doi.org/10.1016/s0140-6736(97)11423-4
                        

Identifiers

DOI: 10.1016/s0140-6736(97)11423-4